THYROXINE (T4) - ANVISA Registration 81327670136

Access comprehensive regulatory information for THYROXINE (T4) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81327670136 and manufactured by LANSION BIOTECHNOLOGY CO., LTD.. The registration is held by DNEDX COMERCIO E SERVICOS PARA PRODUTOS DA SAUDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ORTHO-CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.